Year |
Citation |
Score |
2023 |
Mu A, Klare WP, Baines SL, Ignatius Pang CN, Guérillot R, Harbison-Price N, Keller N, Wilksch J, Nhu NTK, Phan MD, Keller B, Nijagal B, Tull D, Dayalan S, Chua HHC, ... ... Cole JN, et al. Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria. Nature Communications. 14: 1530. PMID 36934086 DOI: 10.1038/s41467-023-37200-w |
0.459 |
|
2019 |
Levin J, Borchardt A, Lam T, Jiang W, Chen Z, Fortier J, Akers-Rodriguez S, Amundson K, Donatelli J, Döhrmann S, Cole J, Tari L. 689. Therapeutic Efficacy of CB-012, a Novel Cloudbreak Antiviral Fc-Conjugate (AVC) in Lethal Mouse Models of Influenza A (H1N1) and Influenza B (Victoria) Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.757 |
0.734 |
|
2018 |
Henningham A, Davies MR, Uchiyama S, van Sorge NM, Lund S, Chen KT, Walker MJ, Cole JN, Nizet V. Virulence Role of the GlcNAc Side Chain of the Lancefield Cell Wall Carbohydrate Antigen in Non-M1-Serotype Group A Streptococcus. Mbio. 9. PMID 29382733 DOI: 10.1128/Mbio.02294-17 |
0.847 |
|
2017 |
Döhrmann S, LaRock CN, Anderson EL, Cole JN, Ryali B, Stewart C, Nonejuie P, Pogliano J, Corriden R, Ghosh P, Nizet V. Group A Streptococcal M1 Protein Provides Resistance against the Antimicrobial Activity of Histones. Scientific Reports. 7: 43039. PMID 28220899 DOI: 10.1038/Srep43039 |
0.746 |
|
2016 |
Stewart CM, Buffalo CZ, Valderrama JA, Henningham A, Cole JN, Nizet V, Ghosh P. Coiled-coil destabilizing residues in the group A Streptococcus M1 protein are required for functional interaction. Proceedings of the National Academy of Sciences of the United States of America. PMID 27512043 DOI: 10.1073/Pnas.1606160113 |
0.678 |
|
2016 |
Döhrmann S, Cole JN, Nizet V. Conquering Neutrophils. Plos Pathogens. 12: e1005682. PMID 27467389 DOI: 10.1371/journal.ppat.1005682 |
0.744 |
|
2016 |
Rivera-Hernandez T, Pandey M, Henningham A, Cole J, Choudhury B, Cork AJ, Gillen CM, Ghaffar KA, West NP, Silvestri G, Good MF, Moyle PM, Toth I, Nizet V, Batzloff MR, et al. Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models. Mbio. 7. PMID 27302756 DOI: 10.1128/Mbio.00618-16 |
0.584 |
|
2016 |
Cole JN, Nizet V. Bacterial Evasion of Host Antimicrobial Peptide Defenses. Microbiology Spectrum. 4. PMID 26999396 DOI: 10.1128/Microbiolspec.Vmbf-0006-2015 |
0.483 |
|
2015 |
Barnett TC, Cole JN, Rivera-Hernandez T, Henningham A, Paton JC, Nizet V, Walker MJ. Streptococcal toxins: role in pathogenesis and disease. Cellular Microbiology. PMID 26433203 DOI: 10.1111/Cmi.12531 |
0.506 |
|
2015 |
Secundino I, Lizcano A, Roupé KM, Wang X, Cole JN, Olson J, Ali SR, Dahesh S, Amayreh LK, Henningham A, Varki A, Nizet V. Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation. Journal of Molecular Medicine (Berlin, Germany). PMID 26411873 DOI: 10.1007/S00109-015-1341-8 |
0.659 |
|
2015 |
Xu D, Olson J, Cole JN, van Wijk XM, Brinkmann V, Zychlinsky A, Nizet V, Esko JD, Chang YC. Heparan Sulfate Modulates Neutrophil and Endothelial Function in Antibacterial Innate Immunity. Infection and Immunity. 83: 3648-56. PMID 26150541 DOI: 10.1128/Iai.00545-15 |
0.606 |
|
2015 |
Henningham A, Döhrmann S, Nizet V, Cole JN. Mechanisms of group A Streptococcus resistance to reactive oxygen species. Fems Microbiology Reviews. 39: 488-508. PMID 25670736 DOI: 10.1093/Femsre/Fuu009 |
0.812 |
|
2014 |
Henningham A, Yamaguchi M, Aziz RK, Kuipers K, Buffalo CZ, Dahesh S, Choudhury B, Van Vleet J, Yamaguchi Y, Seymour LM, Ben Zakour NL, He L, Smith HV, Grimwood K, Beatson SA, ... ... Cole JN, et al. Mutual exclusivity of hyaluronan and hyaluronidase in invasive group A Streptococcus. The Journal of Biological Chemistry. 289: 32303-15. PMID 25266727 DOI: 10.1074/Jbc.M114.602847 |
0.81 |
|
2014 |
van Sorge NM, Cole JN, Kuipers K, Henningham A, Aziz RK, Kasirer-Friede A, Lin L, Berends ET, Davies MR, Dougan G, Zhang F, Dahesh S, Shaw L, Gin J, Cunningham M, et al. The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design. Cell Host & Microbe. 15: 729-40. PMID 24922575 DOI: 10.1016/J.Chom.2014.05.009 |
0.752 |
|
2014 |
Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, Sriprakash KS, Sanderson-Smith ML, Nizet V. Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clinical Microbiology Reviews. 27: 264-301. PMID 24696436 DOI: 10.1128/Cmr.00101-13 |
0.624 |
|
2014 |
Anderson EL, Cole JN, Olson J, Ryba B, Ghosh P, Nizet V. The fibrinogen-binding M1 protein reduces pharyngeal cell adherence and colonization phenotypes of M1T1 group A Streptococcus. The Journal of Biological Chemistry. 289: 3539-46. PMID 24356958 DOI: 10.1074/Jbc.M113.529537 |
0.847 |
|
2013 |
Tsatsaronis JA, Hollands A, Cole JN, Maamary PG, Gillen CM, Ben Zakour NL, Kotb M, Nizet V, Beatson SA, Walker MJ, Sanderson-Smith ML. Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A Streptococcus. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2633-43. PMID 23531597 DOI: 10.1096/Fj.12-226662 |
0.834 |
|
2012 |
Dahesh S, Nizet V, Cole JN. Study of streptococcal hemoprotein receptor (Shr) in iron acquisition and virulence of M1T1 group A streptococcus. Virulence. 3: 566-75. PMID 23076332 DOI: 10.4161/Viru.21933 |
0.636 |
|
2012 |
Cole JN, Aziz RK, Kuipers K, Timmer AM, Nizet V, van Sorge NM. A conserved UDP-glucose dehydrogenase encoded outside the hasABC operon contributes to capsule biogenesis in group A Streptococcus. Journal of Bacteriology. 194: 6154-61. PMID 22961854 DOI: 10.1128/Jb.01317-12 |
0.795 |
|
2012 |
Maamary PG, Ben Zakour NL, Cole JN, Hollands A, Aziz RK, Barnett TC, Cork AJ, Henningham A, Sanderson-Smith M, McArthur JD, Venturini C, Gillen CM, Kirk JK, Johnson DR, Taylor WL, et al. Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4675-84. PMID 22878963 DOI: 10.1096/Fj.12-212142 |
0.806 |
|
2012 |
Henningham A, Chiarot E, Gillen CM, Cole JN, Rohde M, Fulde M, Ramachandran V, Cork AJ, Hartas J, Magor G, Djordjevic SP, Cordwell SJ, Kobe B, Sriprakash KS, Nizet V, et al. Conserved anchorless surface proteins as group A streptococcal vaccine candidates. Journal of Molecular Medicine (Berlin, Germany). 90: 1197-207. PMID 22527883 DOI: 10.1007/S00109-012-0897-9 |
0.577 |
|
2011 |
Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nature Reviews. Microbiology. 9: 724-36. PMID 21921933 DOI: 10.1038/Nrmicro2648 |
0.627 |
|
2011 |
Amelung S, Nerlich A, Rohde M, Spellerberg B, Cole JN, Nizet V, Chhatwal GS, Talay SR. The FbaB-type fibronectin-binding protein of Streptococcus pyogenes promotes specific invasion into endothelial cells. Cellular Microbiology. 13: 1200-11. PMID 21615663 DOI: 10.1111/J.1462-5822.2011.01610.X |
0.479 |
|
2011 |
Macheboeuf P, Buffalo C, Fu CY, Zinkernagel AS, Cole JN, Johnson JE, Nizet V, Ghosh P. Streptococcal M1 protein constructs a pathological host fibrinogen network. Nature. 472: 64-8. PMID 21475196 DOI: 10.1038/Nature09967 |
0.658 |
|
2010 |
Cole JN, Pence MA, von Köckritz-Blickwede M, Hollands A, Gallo RL, Walker MJ, Nizet V. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. Mbio. 1. PMID 20827373 DOI: 10.1128/Mbio.00191-10 |
0.84 |
|
2010 |
Pence MA, Rooijakkers SH, Cogen AL, Cole JN, Hollands A, Gallo RL, Nizet V. Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. Journal of Innate Immunity. 2: 587-95. PMID 20814187 DOI: 10.1159/000317672 |
0.828 |
|
2010 |
Maamary PG, Sanderson-Smith ML, Aziz RK, Hollands A, Cole JN, McKay FC, McArthur JD, Kirk JK, Cork AJ, Keefe RJ, Kansal RG, Sun H, Taylor WL, Chhatwal GS, Ginsburg D, et al. Parameters governing invasive disease propensity of non-M1 serotype group A streptococci. Journal of Innate Immunity. 2: 596-606. PMID 20814186 DOI: 10.1159/000317640 |
0.83 |
|
2008 |
Sanderson-Smith ML, Dinkla K, Cole JN, Cork AJ, Maamary PG, McArthur JD, Chhatwal GS, Walker MJ. M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolate. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2715-22. PMID 18467595 DOI: 10.1096/fj.07-105643 |
0.489 |
|
2007 |
Cole JN, Aquilina JA, Hains PG, Henningham A, Sriprakash KS, Caparon MG, Nizet V, Kotb M, Cordwell SJ, Djordjevic SP, Walker MJ. Role of group A Streptococcus HtrA in the maturation of SpeB protease. Proteomics. 7: 4488-98. PMID 18072207 DOI: 10.1002/Pmic.200700626 |
0.601 |
|
2007 |
Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, Henningham A, McArthur JD, Dinkla K, Aziz RK, Kansal RG, Simpson AJ, Buchanan JT, Chhatwal GS, Kotb M, Nizet V. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nature Medicine. 13: 981-5. PMID 17632528 DOI: 10.1038/Nm1612 |
0.821 |
|
2006 |
Cole JN, McArthur JD, McKay FC, Sanderson-Smith ML, Cork AJ, Ranson M, Rohde M, Itzek A, Sun H, Ginsburg D, Kotb M, Nizet V, Chhatwal GS, Walker MJ. Trigger for group A streptococcal M1T1 invasive disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1745-7. PMID 16790522 DOI: 10.1096/Fj.06-5804Fje |
0.496 |
|
Show low-probability matches. |